Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial.
about
Cardiac Remodeling, Circulating Biomarkers and Clinical Events in Patients with a History of Atrial Fibrillation. Data from the GISSI-AF Trial.The expression levels of plasma micoRNAs in atrial fibrillation patients.Induction of atrial fibrillation by neutrophils critically depends on CD11b/CD18 integrins.Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope.Anti-inflammatory effect of factor-Xa inhibitors in Japanese patients with atrial fibrillation.The significance of the left atrial volume index in prediction of atrial fibrillation recurrence after electrical cardioversion.Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic StrokePentraxin 3 is a local inflammatory marker in atrial fibrillation.Idiopathic dilated cardiomyopathy and chronic atrial fibrillation.Interleukin-37 elevation in patients with atrial fibrillation.Pentraxin 3 and other inflammatory biomarkers related to atrial fibrillation in cardiac surgery.
P2860
Q31019192-4C074C2A-CE25-44B7-B285-E0498FAA2DAAQ34427635-739E80A4-0DC7-4328-A645-B4AD1AB3D709Q35099851-89E900C6-4823-469C-B6ED-E9CE33DB9823Q35609742-452B9AA7-AF19-4E95-A13B-7966679ED3B0Q35756480-BFB23968-4EB8-431F-B420-843FEC8BD045Q37495877-5F34AA27-558D-4027-A7D0-88A39FC1A29DQ37947093-CA150253-906B-4164-AC8D-3AF1627A318DQ38747406-FCCE80D1-D0DC-4375-B985-AD593A6AFEBCQ38815737-80C745DA-B061-4957-85B2-AB82336CC918Q41146607-EE323FBF-7505-4DC0-85A7-31D19AD22F10Q43824291-A37263A6-34E4-4BDA-9045-2424B7EE993EQ47952787-C40299D2-C952-4DBE-8C96-8C21EC216048Q50868896-6AB9234B-930B-4F01-9BA3-1DDFBF658131Q51063579-1AA2C92A-3C71-4529-B4DE-AF38F9CAA5E3
P2860
Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Predicting atrial fibrillation ...... SSI atrial fibrillation trial.
@ast
Predicting atrial fibrillation ...... SSI atrial fibrillation trial.
@en
type
label
Predicting atrial fibrillation ...... SSI atrial fibrillation trial.
@ast
Predicting atrial fibrillation ...... SSI atrial fibrillation trial.
@en
prefLabel
Predicting atrial fibrillation ...... SSI atrial fibrillation trial.
@ast
Predicting atrial fibrillation ...... SSI atrial fibrillation trial.
@en
P2093
P50
P356
P1433
P1476
Predicting atrial fibrillation ...... SSI atrial fibrillation trial.
@en
P2093
Aneta Aleksova
Carmine Mazzone
Chiara Belvito
Chiara Favero
Federico Bertocchi
GISSI-AF investigators
Giovanni Cioffi
Giuseppe Peri
Ivan Cuccovillo
Lidia Staszewsky
P304
P356
10.1136/HRT.2009.191460
P407
P577
2010-10-21T00:00:00Z